A Novel, Simple Method for Detection of Caffeine in Urine as a Predictive Marker for Liver Diseases
DOI:
https://doi.org/10.37256/acbr.2120231639Keywords:
liver function markers, diagnosis, caffeine, urine, phosphomolybdic acidAbstract
Drugs, chemicals, and endogenous substrates are all metabolized by hepatic cytochrome P450 (CYP) which plays a role in the aetiology of a variety of liver illnesses. Caffeine is completely metabolized by CYPs. Caffeine excretion in the urine is a sign of liver damage. The study aimed to develop and validate an inexpensive, simple, and rapid method for determining urinary caffeine as a diagnostic marker for liver diseases. Caffeine in urine sample underwent hydrolysis. Strip containing phosphomolybdic acid (PMA) was used to detect the hydrolysis product of caffeine in urine. The interaction of caffeine with PMA produced a blue color on the strip. The current method helps analyze caffeine in urine, providing a simple, rapid, and economic routine analysis.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Sarah Ali Qutb, Mariam Ahmed Moustafa, Mirna Fawzy Nazmi, Ahmed Hany Abed Mahmoud, George Safwat Mounir Abdel Masih, Safa Gamal Abdel Fattah Suleiman, Mary Karam Arian Amen, Mohamed Omar Ewis Khamis, Ayman Saber Mohamed
This work is licensed under a Creative Commons Attribution 4.0 International License.